Abstract
Background/Aims
The relationship between Helicobacter pylori and celiac disease (CD) remains controversial. The aim of this study was to assess the prevalence and risk factors for H. pylori infection among children diagnosed with CD.
Materials and Methods
This study included 70 patients diagnosed with CD at a tertiary referral center in Romania. Age, gender, and indicators of environmental conditions were evaluated via interviews with the children’s caretakers. A multivariable logistic regression analysis was performed to identify the independent predictors for H. pylori infection.
Results
Of the 70 patients, 37 (52.9%) were females, and the mean age was 4.04±3.26 years. H. pylori infection was diagnosed in 23 (32.8%) patients, of whom 12 (52.1%) were females, and the mean age was 6.2±4.5 years. Of the total number of children with CD and H. pylori infection, 18 (78.2%) had milder forms of enteropathy (Marsh I–II), whereas the remaining 5 (21.7%) had villous atrophy compared to the other 47 (67.2%) patients who were negative for H. pylori-infection and showed more severe intestinal damage. The development of H. pylori infection was independently related to children with one parent only [odd ratio (OR), 9.04; 95% confidence interval (CI), 1.29–62.89; p<0.001], living in houses without sanitary facilities (OR, 3.88; 95% CI, 1.27–14.22; p=0.016), belonging to low-income families (OR, 8.52; 95% CI, 2.52–71.39; p=0.002), and of parents with a prior history of gastritis (OR, 2.68; 95% CI, 1.49–14.50; p=0.004).
Conclusion
Children with CD and H. pylori infection had milder forms of enteropathy compared to children who are negative for H. pylori, suggesting that H. pylori infection may confer some protection against the development of severe degrees of villous atrophy.
Keywords: Helicobacter pylori, celiac disease, children, prevalence
INTRODUCTION
Celiac disease (CD) is a chronic, multiorgan autoimmune condition affecting the small intestine in genetically predisposed children and adults, precipitated by the ingestion of gluten-containing foods (1). The etiology of CD is not yet completely understood, and its increasing prevalence has led to a change of optics concerning a number of environmental risk factors, such as exposure to bacterial antigens, including Helicobacter pylori, that may trigger an autoimmune process in the small bowel (2). Although H. pylori is one of the most common chronic bacterial infections worldwide and the causative agent of several gastric conditions [chronic gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer], the majority of infected individuals remain asymptomatic (3).
Data are scarce on the epidemiology of CD in Romania, with a reported prevalence ranging from 3.9% to 6% for adult patients (4,5) and from 4.09% to 9.2% for children with type I diabetes mellitus (6,7). In a multicenter study including 2436 adult patients who underwent esogastroduodenoscopy in Romania, the overall prevalence of CD was estimated to be 2.22% (8). Regarding the prevalence of H. pylori infection in Romania, the studies are also scarce and heterogeneous with respect to reporting significant differences among geographic regions and the methods of diagnosis (culture, histology, rapid urease test, real-time polymerase chain reaction, serology, stool antigen test, and urea breath test). One study has reported a prevalence of 53.3% for H. pylori infection in adult patients with gastroesophageal reflux disease (9). Another study investigating the prevalence of H. pylori infection using the urease test reported an increased prevalence with age, ranging from 50% in patients younger than 20 years to 81.4% among adult patients (51–60 years) (10).
In children, the studies are also few, with an estimated prevalence of 10.5% among those younger than 7 years of age, 39.1% among school children, and 46.3% among adolescents (11). A high prevalence rate of 20% was also reported for H. pylori infection among the adopted Romanian children who underwent serological screening (12). In the northeastern part of Romania, Burlea et al. (13) found an overall prevalence of 48.25% for H. pylori infection among 2130 children with dyspeptic symptoms that was more common in older children (13–16 years, 57.76%).
Several studies have shown that the prevalence of H. pylori infection is decreasing in both adults and children, whereas the prevalence of CD has an increasing trend (14). This paradigm, which is common in infectious conditions, may also apply to CD wherein luminal factors may trigger a clinically overt disease in genetically susceptible hosts (15,16). H. pylori is typically acquired during the first few years of life, whereas CD can develop at any time, nevertheless, much later than infancy (17).
Data are limited on the relationship between H. pylori infection and CD, which remains controversial (18). Specifically, H. pylori bacterium induces microscopic duodenal inflammation and can consequently be related to more severe damage when associated with CD although other publications have suggested an inverse relationship between these two conditions, suggesting the possibility that H. pylori infection may have a protective role against the risk of CD development (19,20).
We aimed to determine the prevalence and risk factors for H. pylori infection among children with the diagnosis of CD from the northeastern part of Romania.
MATERIALS AND METHODS
This is a retrospective analysis of children admitted and diagnosed with CD from January 10, 2014, to December 10, 2016, at the Gastroenterology Department, a tertiary center in the northeastern part of Romania. Children between 3 and 14 years of age diagnosed with CD were eligible for the study. The patients’ medical charts were carefully reviewed, and demographic information including age, gender, clinical and laboratory parameters, prior hospitalizations, and environmental and socioeconomic statuses were assessed.
The positive diagnosis of CD was based on the presence of characteristic duodenal enteropathy, which can range from intraepithelial lymphocytosis (LIEs) to total villous flattening; positive serology for specific antibodies, mainly those directed against type 2 tissue transglutaminase (tTG); and CD-associated symptoms.
The total immunoglobulin A (IgA) level was tested in all subjects. In case of IgA deficiency, the corresponding antibodies were measured in the IgG class. Serum IgA-tTG and IgA-antigliadine (AGA) antibodies were determined using a commercially available enzyme-linked immunosorbent assay kit according to the manufacturers’ instructions and cutoff values. Serum tTG values ≥8.0 U and serum AGA values ≥12.0 U were considered positive (Celikey, Phadia GmbH, Freiburg, Germany).
During upper endoscopy, minimum three biopsy specimens were obtained from the bulb and distal duodenum. The degree of mucosal damage was further graded according to the standard Marsh-Oberhuber classification: Marsh 0 represents normal mucosa; Marsh I stands for increased LIEs (>25/100 enterocytes); Marsh II for hyperplastic crypts; and Marsh III grades are partial (a), subtotal (b), or total (c) villous atrophy (21,22). A single experienced pathologist who was blinded to all of patients’ clinical data examined the biopsies. In case of patchy mucosal lesions, the final Marsh score for each patient was graded according to the most affected site. Two biopsy specimens were obtained from the gastric antral mucosa. Biopsies were fixed in formalin overnight, embedded in paraffin, and stained with hematoxylin-eosin and Giemsa for routine evaluation. H. pylori infection was considered positive when bacterium was present in at least one of the stained sections of the biopsy. Upper endoscopy and biopsy sampling were performed with parents’ or legal guardians’ prior informed consent.
The participants were classified into two groups according to the presence/absence of H. pylori: patients with CD and H. pylori infection (study group) were compared with those without H. pylori infection (control group).
This retrospective study was performed in accordance with the principles outlined in the Declaration of Helsinki. Given the retrospective nature of the study, no institutional approval was required.
Statistical analysis
Continuous variables were presented as mean±standard deviation and categorical variables as frequency and percentage. The Student’s t test was used to compare normally distributed continuous variables, and the Mann-Whitney U test was used for variables without normal distribution. The chi-square test and Fisher approximation method were used to compare categorical variables. Univariate analysis was performed for each recorded variable. Variables with p<0.1 in the univariate analysis were included in the multivariate analysis. For adjusted effect, we used the logistic regression. The level of statistical significance was defined as p<0.05. Data were analyzed using the Statistical Package for Social Sciences (SPSS) software version 19.0 for Windows (IBM Corp.; Armonk, NY, USA).
RESULTS
Of the 70 children who were enrolled, 37 (52.9%) were females, and the mean age was 4.04±3.26 years (range, 3–14 years). Among them, 23 (32.8%) patients were diagnosed with H. pylori infection, with 12 (52.1%) females and a mean age of 6.2±4.5 years (range, 4–14 years). Demographics, clinical and laboratory characteristics of patients with and without H. pylori infection are shown in Table 1. The study also investigated the epidemiology of H. pylori infection among Romanian children from different environments within the same geographical area. Therefore, 61.5% lived in the adjoining urban area and 38.5% came from rural villages. However, H. pylori prevalence was higher among children residing in the rural areas, 14 (60.8%), p=0.015. Most of those with H. pylori infection were older than 5 years (65.2%), from single-parent families (60.8%, p<0.001), belonged to low-income families (p<0.001), and of parents with a prior history of gastritis or ulceropeptic disease (p<0.001). There was no significant difference concerning gender distribution, clinical features, most laboratory parameters, and family history of CD between patients with CD and H. pylori infection and those with CD without H. pylori infection. Children with precarious hygiene and poor sanitation conditions in the selected household were more likely to present with H. pylori infection (p=0.004).
Table 1.
Characteristics of all patients with and without H. pylori infection
| Variables | Patients (n=70) | H. pylori positive (n=23) | H. pylori negative (n=47) | p |
|---|---|---|---|---|
| Gender, female, n, % | 37 (52.9) | 12 (32.4) | 25 (67.5) | 0.930 |
| Age>5 years, n, % | 23 (32.9) | 15 (65.2) | 8 (17) | <0.001 |
| Rural, n, % | 27 (38.5) | 14 (60.8) | 13 (27.6) | 0.015 |
| Family history of CD, n, % | 7 (10) | 4 (17.4) | 3 (6.4) | 0.30 |
| Low family income, n, % | 24 (34.2) | 19 (82.6) | 5 (10.6) | <0.001 |
| Attending school, kindergarten, nursery, n,% | 24 (34.2) | 14 (60.8) | 10 (21.2) | 0.003 |
| Houses without toilets or sanitary facilities, n, % | 28 (40) | 15 (65.2) | 13 (27.6) | 0.004 |
| Parents with a prior history of gastritis or peptic ulcer disease, n, % | 26 (37.1) | 17 (73.9) | 9 (19.1) | <0.001 |
| Single parent family, n, % | 18 (25.7) | 14 (60.8) | 4 (8.5) | <0.001 |
| Biochemical and serological parameters (mean±SD) | ||||
| Hemoglobin (g/dL) | 11.67±1.35 | 12.23±1.76 | 11.62±1.12 | 0.207 |
| Iron (μg/dL) | 57.69±38.02 | 32.1±21.3 | 36.9±19.1 | 0.361 |
| AST (IU/L) | 60.55±16.4 | 73.73±35.44 | 44.79±5.19 | 0.198 |
| ALT(IU/L) | 36.18±86.96 | 95.6±21.2 | 44.2±2.8 | 0.273 |
| IgA-tTG (U/mL) | 58.48±19.4 | 73.5±2.5 | 59.6±7.8 | 0.790 |
| IgA-AGA (U/mL) | 42.66±28.61 | 51.8±3.3 | 38.5±2.5 | 0.048 |
| Histology | ||||
| Marsh I–II, n, % | 32 (45.7) | 18 (78.2) | 14 (29.7) | <0.001 |
| Marsh IIIa–c, n, % | 38 (54.2) | 5 (21.7) | 33 (70.2) | <0.001 |
| Reason for referral | ||||
| Heartburn, n, % | 35 (50) | 15 (65.2) | 20 (42.5) | 0.12 |
| Vomiting, n, % | 37 (52.9) | 18 (78.2) | 19 (40.4) | 0.064 |
| Abdominal pain, n, % | 35 (50) | 18 (78.2) | 17 (36.1) | 0.087 |
| Chronic diarrhea, n, % | 34 (48.6) | 13 (56.5) | 21 (44.7) | 0.44 |
Data given in absolute numbers, frequencies, or mean±SD. SD: standard deviation; CD: celiac disease; AST: aspartate aminotransferase; ALT: alanine aminotransferase; IgA-tTG: immunoglobulin A-type 2 tissue transglutaminase antibodies; IgA-AGA: immunoglobulin A-antigliadine antibodies
There were significant differences in the distribution of Marsh severity scores between the two study groups, with a greater proportion of the patients who were negative for H. pylori infections graded with villous atrophy. Of the children with CD and H. pylori, 18 (78.2%) had milder forms of enteropathy (Marsh I–II), and the remaining 5 (21.7%) had villous atrophy compared to 47 (67.2%) patients who were negative for H. pylori infections and showed more severe intestinal damage, including 19 (40.4%) with subtotal villous atrophy and 14 (29.7%) with complete villous atrophy (p<0.001). Our results suggest a slight trend toward milder duodenal lesions in patients with H. pylori infection compared to the non-infected patients. Variables with a p<0.1 in the univariate analysis were included in the multivariate logistic regression; the results are presented in Table 2.
Table 2.
Univariate and multivariate regression analysis of risk factors associated with H. pylori infection in children with CD
| Parameter | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| OR | 95% CI | P value | OR | 95% CI | p | |
| Gender, female | 0.96 | 0.35–2.60 | 0.93 | 0.24 | 0.012–1.45 | 0.733 |
| Age>5 years | 9.14 | 2.90–28.77 | <0.001 | 1.91 | 0.13–27.00 | 0.630 |
| Low family income | 39.9 | 9.62–165.4 | <0.001 | 8.52 | 2.52–71.39 | 0.002 |
| Attending school, kindergarten, nursery | 5.75 | 1.93–17.12 | 0.003 | 1.79 | 0.13–24.62 | 0.664 |
| Houses without toilets or sanitary facilities | 4.90 | 1.68–14.29 | 0.004 | 3.88 | 1.27–14.22 | 0.016 |
| Parents with prior history of gastritis or peptic ulcer disease | 11.96 | 3.67–38.96 | <0.001 | 2.68 | 1.49–14.50 | 0.004 |
| Single parent family | 16.72 | 4.45–62.80 | <0.001 | 9.04 | 1.29–62.89 | <0.001 |
| Rural household | 4.06 | 1.41–11.66 | 0.015 | - | - | - |
| Family history of CD | 3.08 | 0.62–15.15 | 0.30 | - | - | - |
| Marsh I–II | 8.48 | 2.62–27.38 | <0.001 | - | - | - |
| Marsh IIIa–c | 0.112 | 0.036–0.38 | <0.001 | - | - | - |
Data presented as OR: odds ratio; CI: confidence interval; CD: celiac disease
Single-parent families [odds ratio (OR), 9.04; 95% confidence interval (CI), 1.29–62.89; p<0.001], houses without toilets or sanitary facilities (OR, 3.88; 95% CI, 1.27–14.22; p=0.016), low-income families (OR, 8.52; 95% CI, 2.52–71.39; p=0.002), and parents’ with a prior history of gastritis or peptic ulcer disease (OR, 2.68; 95% CI, 1.49–14.50; p=0.004) were the indicators independently associated with the development of H. pylori infection in children with CD.
DISCUSSION
The relationship between CD and H. pylori remains controversial; however, some studies have reported that H. pylori infection appears to confer protection against CD (23). Lebowhl et al. (19) performed a cross-sectional study among patients undergoing upper endoscopy and found an inverse relationship between these two entities after adjusting for age and socioeconomic factors. Patients with CD had lower rates of H. pylori infection than those with normal duodenal mucosa, suggesting a guarding role for H. pylori against the development of CD, which was also implied by other studies (19,20).
Villanacci et al. (24) assessed the hypothesis that H. pylori could modulate gluten immunogenicity among genetically susceptible patients in a study including 80 adult patients with CD evaluated before and after the gluten-free diet. The authors concluded that patients with CD and H. pylori infection had milder duodenal lesions compared to those without H. pylori infection, and the diet was equally effective in infected as well as non-infected patients with CD (24). These histological evidences were not supported by other publications. Guz-Mark et al. (25) demonstrated that the presence of H. pylori infection does not influence the severity of the duodenal lesions. Similar results were reported by another study that found an identical degree of mucosal damage among patients with CD and H. pylori compared to non-infected individuals (26).
However, numerous epidemiological studies available in literature failed to find significant differences in H. pylori prevalence among patients with CD and control groups. Diamanti et al. (27) found lower prevalence rates of H. pylori infection compared to controls in 1999 although results were reported later in 2009 (28). Rostami-Nejad et al. (28) argue that the simultaneous presence of H. pylori gastritis does not influence the clinical features or the severity of mucosal damage in CD. In contrast, Aydogdu et al. (29) found no differences in the prevalence of H. pylori infection in patients with and without CD. An interesting result was reported by Konturek et al. (30) who suggested an increased H. pylori seroprevalence among patients with CD with a lower prevalence of Cag-positive strains in infected subjects with CD than in infected controls, implying a potential relationship between H. pylori virulence and CD (31).
The frequency rate and risk factors for contamination by H. pylori infection were investigated in a number of studies. Yücel et al. (32) observed that poorly educated mothers, lower family income, inadequate living conditions, and higher numbers of siblings correlated with higher H. pylori infections in children. Children living in poor conditions, cared for by mothers lacking education were at higher risk for H. pylori infection. Additionally, other studies have reported that exposure to an infected subject with gastroenteritis living in the same household, residence in day-care centers, child-to-child transmission in kindergartens, and living conditions that are often crowded and lack indoor plumbing are additional factors influencing the prevalence of H. pylori infection (30–33).
This study investigated the prevalence and risk factors for H. pylori infection among children with an established diagnosis of CD. We found that H. pylori colonization among children with CD is not influenced by gender or household residence. No significant differences were found concerning clinical features, laboratory parameters, or a family history of CD between patients with CD and H. pylori infection and those with CD without H. pylori infection. Similar to other studies, we found minor insignificant differences related to the serum levels of IgA-tTG in patients who were positive for H. pylori compared to those who were negative (2). However, some children who were positive for H. pylori expressed mild elevation of IgA-AGA levels, compared to those who are negative for H. pylori. Regarding histological changes, we found that a greater proportion of patients with CD and H. pylori infection presented milder forms of enteropathy compared to those who were negative for H. pylori and showed more severe intestinal damage, including complete villous atrophy; these results were also reported by Villanacci et al. (24) and Aydogdu et al. (29). A particular finding of our study was the correlation between H. pylori prevalence and the severity of histological duodenal features in patients with CD. Our results suggest a slight trend toward milder duodenal lesions among patients with H. pylori infection.
We may conclude that the prevalence rates for CD and H. pylori infection differ mainly with respect to the socioeconomic status. The source of H. pylori is intra-familial rather than community-acquired in nursery or kindergarten attended at a young age. Contact with infected family members and crowded living conditions were associated with an increased risk of infection. Factors, such as monoparental families, houses without toilets or sanitary conditions, families with low incomes, and parents’ prior history of gastritis or peptic ulcer, remained independently associated with the development of H. pylori infection in children with CD.
Despite its limitations, our study has a number of strengths. It is the first study conducted in the northeastern part of Romania at a tertiary referral center to evaluate the prevalence and risk factors for H. pylori infection in children with CD. However, as a retrospective, single center study, it is prone to bias. The main limitation of this investigation is the small size of the sample and the retrospective study design. Therefore, the temporality of exposure and outcome for study participants could not be assessed.
In conclusion, we found that the prevalence of H. pylori infection as well as the risk factors among children with established diagnosis of CD seems to be in range with data reported in children without CD in the northeastern region of Romania. Children with CD and H. pylori infection had milder forms of enteropathy compared to those who were negative for H. pylori, suggesting that H. pylori infection may have a protective role against the development of severe forms of villous atrophy. Additional studies are needed to assess the association between H. pylori infection and CD in children and the potential protective or damaging role of H. pylori-strains that could explain, at least to some extent, the conflicting results available to date.
Footnotes
Ethics Committee Approval: N/A.
Informed Consent: Written informed consent was obtained from the patients’ parents or legal guardians who participated in this study.
Peer-review: Externally peer-reviewed.
Author Contributions: Concept R.M., A.P., C.S., I.G., E.M., A.T.; Design - R.M., A.P., C.S., I.G., E.M., A.T.; Supervision - R.M., A.P., C.S., I.G., E.M., A.T.; Resources - C.S., E.M., A.T.; Materials - E.M.; Data Collection and/or Processing - R.M., I.G.; Analysis and/or Interpretation - A.P., A.T.; Literature Search - C.S., A.P.; Writing Manuscript - R.M., C.S.; Critical Reviews - A.T., C.S., E.M.
Conflict of Interest: The authors have no conflict of interest to declare.
Financial Disclosure: The authors declared that this study has received no financial support.
REFERENCES
- 1.Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52. doi: 10.1136/gutjnl-2011-301346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Basyigit S, Unsal O, Uzman M, et al. Relationship between Helicobacter pylori infection and celiac disease: a cross-sectional study and a brief review of the literature. Prz Gastroenterol. 2017;12:49–54. doi: 10.5114/pg.2017.65681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449–90. doi: 10.1128/CMR.00054-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cev EZ, Pascu O, Serban V, Mulder CJ, Taban S, Samasca G. The prevalence of celiac disease in adult and adolescent Romanian patients with type 1 diabetes mellitus. TMJ. 2010;60:189–95. [Google Scholar]
- 5.Cev EZ, Pascu O, Taban S. Importance of duodenal biopsy during routine upper gastrointestinal endoscopy for diagnosis of celiac disease. J Exp Med Surg Res. 2010;1:23–27. [Google Scholar]
- 6.Belei O, Simedrea I, Marazan M, et al. Correlation of villous alterations in celiac disease pediatric patients with risk factors analyse. Rom J Pediatr. 2009;12:40–4. [Google Scholar]
- 7.Gabriel S, Mihaela I, Angela B, Mariana A, Doru D. Prevalence of IgA antitissue transglutaminase antibodies in children with type 1 diabetes mellitus. J Clin Lab Anal. 2011;25:156–61. doi: 10.1002/jcla.20449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Dobru D, Pascu O, Tantau M, et al. The prevalence of celiac disease at endoscopy units in Romania: routine biopsies during gastroscopy are mandatory. Rom J Gastroenterol. 2003;12:97–100. [PubMed] [Google Scholar]
- 9.Klitorakis I, Stanciu C. Prevalence of Helicobacter pylori infection in patients with gastroesophageal reflux disease. Rev Med Chir Soc Med Nat. 2010;114:80–4. [PubMed] [Google Scholar]
- 10.Andreica V, Andreica M. Infectia cu Helicobacter pylori în bolile stomacului şi duodenului. In: Georgenscu D, Dragomirescu C, editors. Tratat de Gastroenterologie. 2nd ed. Grigorescu M: Medicala Nationala; 2001. pp. 373–80. [Google Scholar]
- 11.Slăvescu KC, Şarban C, Pîrvan A, Gheban D, Mărgescu C, Miu N. Prevalence of Helicobacter pylori infection in children with gastritis and peptic ulcer disease in north-western and central Romania. Clujul Medical. 2012;85:457–62. [Google Scholar]
- 12.Miller LC, Kelly N, Tannemaat M, Grand RJ. Serologic prevalence of antibodies to Helicobacter pylori in internationally adopted children. Helicobacter. 2003;8:173–8. doi: 10.1046/j.1523-5378.2003.00141.x. [DOI] [PubMed] [Google Scholar]
- 13.Burlea M. Helicobacter pylori în patologia gastroduodenală la copil. In: Stanciu C, editor. Helicobacter pylori în patologia umană. Bucureşti, MD: Edit DAN Press; 2001. pp. 174–91. [Google Scholar]
- 14.Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:823–36. doi: 10.1016/j.cgh.2017.06.037. [DOI] [PubMed] [Google Scholar]
- 15.Ozbey G, Hanafiah A. Epidemiology, diagnosis, and risk factors of Helicobacter pylori infection in children. Euroasian J Hepatogastroenterol. 2017;7:34–9. doi: 10.5005/jp-journals-10018-1208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Dore MP, Salis R, Loria MF, Villanacci V, Bassotti G, Pes GM. Helicobacter pylori infection and occurrence of celiac disease in subjects HLA-DQ2/DQ8 positive: A prospective study. Helicobacter. 2018;23:e12465. doi: 10.1111/hel.12465. [DOI] [PubMed] [Google Scholar]
- 17.Ivarsson A, Myléusm A, Norström F, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics. 2013;131:e687–94. doi: 10.1542/peds.2012-1015. [DOI] [PubMed] [Google Scholar]
- 18.Rostami-Nejad M, JavadEhsani-Ardakani M, Assadzadeh H, et al. Pathological and clinical correlation between celiac disease and helicobacter pylori infection; a review of controversial reports. Middle East J Dig Dis. 2016;8:85–92. doi: 10.15171/mejdd.2016.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lebwohl B, Blaser MJ, Ludvigsson JF, et al. Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol. 2013;178:1721–30. doi: 10.1093/aje/kwt234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Narang M, Puri AS, Sachdeva S, Singh J, Kumar A, Saran RK. Celiac disease and Helicobacter pylori infection in children: Is there any Association? J Gastroenterol Hepatol. 2017;32:1178–82. doi: 10.1111/jgh.13654. [DOI] [PubMed] [Google Scholar]
- 21.Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”) Gastroenterology. 1992;102:330–54. doi: 10.1016/0016-5085(92)91819-P. [DOI] [PubMed] [Google Scholar]
- 22.Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94. doi: 10.1097/00042737-199910000-00019. [DOI] [PubMed] [Google Scholar]
- 23.Jansson-Knodell C, Hujoel IA, Tapia AR, Murray J. Not all that flattens villi is celiac disease: a review of enteropathies. Dig Liv Dis. 2018;93:509–17. doi: 10.1016/j.mayocp.2017.10.025. [DOI] [PubMed] [Google Scholar]
- 24.Villanacci V, Bassotti G, Liserre B, Lanzini A, Lanzarotto F, Genta RM. Helicobacter pylori infection in patients with celiac disease. Am J Gastroenterol. 2006;101:1880–5. doi: 10.1111/j.1572-0241.2006.00621.x. [DOI] [PubMed] [Google Scholar]
- 25.Guz-Mark A, Zevit N, Morgenstern S, Shamir R. Duodenal intraepithelial lymphocytosis is common in children without coeliac disease, and is not meaningfully influenced by Helicobacter pylori infection. Aliment Pharmacol Ther. 2014;39:1314–20. doi: 10.1111/apt.12739. [DOI] [PubMed] [Google Scholar]
- 26.Lasa J, Zubiaurre I, Dima G, Peralta D, Soifer L. Helicobacter pylori prevalence in patients with celiac disease: results from a cross-sectional study. Arq Gastroenterol. 2015;52:139–42. doi: 10.1590/S0004-28032015000200012. [DOI] [PubMed] [Google Scholar]
- 27.Diamanti A, Maino C, Niveloni S, et al. Characterization of gastric mucosal lesions in patients with celiac disease: a prospective controlled study. Am J Gastroenterol. 1999;94:1313–9. doi: 10.1111/j.1572-0241.1999.01082.x. [DOI] [PubMed] [Google Scholar]
- 28.Rostami-Nejad M, Rostami K, Yamaoka Y, et al. Clinical and histological presentation of Helicobacter pylori and gluten related gastroenteropathy. Arch Iran Med. 2011;14:115–8. [PMC free article] [PubMed] [Google Scholar]
- 29.Aydogdu S, Cakir M, Yuksekkaya HA, et al. Helicobacter pylori infection in children with celiac disease. Scand J Gastroenterol. 2008;43:1088–93. doi: 10.1080/00365520802101846. [DOI] [PubMed] [Google Scholar]
- 30.Konturek PC, Karczewska E, Dieterich W, Hahn EG, Schuppan D. Increased prevalence of Helicobacter pylori infection in patients with celiac disease. Am J Gastroenterol. 2000;95:3682–3. doi: 10.1111/j.1572-0241.2000.03421.x. [DOI] [PubMed] [Google Scholar]
- 31.Marcus EA, Sachs G, Scott DR. Acid-regulated gene expression of Helicobacter pylori: insight into acid protection and gastric colonization. Helicobacter. 2018:e12490. doi: 10.1111/hel.12490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Yücel O, Sayan A, Yildiz M. The factors associated with asymptomatic carriage of Helicobacter pylori in children and their mothers living in three socio-economic settings. Jpn J Infect Dis. 2009;62:120–4. [PubMed] [Google Scholar]
- 33.Zhou Y, Ye Z, Huang J, Huang Y, Yan W, Zhang Y. High prevalence and low spontaneous eradication rate of Helicobacter pylori infection among schoolchildren aged 7–12 years. Acta Paediatr. 2018 doi: 10.1111/apa.14387. doi: 10.1111/apa.14387. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
